Specialty
Aesthetics Cataract & Refractive Dermatology General Ophthalmology Glaucoma Interventional Radiology Neurology Optometry Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Search
Log In

New Options in Glaucoma Pharmacology: Targeting the TM

By: Albert S. Khouri, MD; Gagan Sawhney, MD

Webinar Credits: 1

New options have become available in recent years for the medical management of glaucoma. Drs. Khouri and Sawhney discuss the importance of individualized care for patients, with an emphasis on lowering IOP through enhancing trabecular meshwork outflow using novel therapies rather than surgical options as first-line treatment.

TARGET AUDIENCE
This certified CME/CE activity is designed for specialists and other allied eye care practitioners involved in the management of glaucoma and associated disorders.

Expiration Date: Thursday, April 20, 2023
Release Date: April 2020

Learning Objectives

At the completion of this educational activity, you will be better able to:

  • Identify the mechanisms of action as well as the efficacy and safety profiles of novel trabecular outflow medications.
  • Demonstrate proficiency in selecting appropriate therapies to achieve individualized patient-specific treatment goals.
  • Advocate for patients who would benefit from new drugs before they are incorporated into payors’ formularies.

Accreditation and Designation Statement

Accreditation Statement
Evolve Medical Education LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
Evolve Medical Education LLC designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This course is COPE approved for 1.0 hour of CE credit for optometrists.

Sponsored by: State University of New York College of Optometry

Evolve is an approved COPE Administrator.

COPE Course ID: 67918-GL

COPE Event ID: 119353

 

This educational activity is provided by Evolve Medical Education

 

Faculty and Disclosures

DISCLOSURE POLICY

It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Albert S. Khouri, MD and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie, Allergan, and Glaukos. Grant/Research Support: Allergan. Speaker’s Bureau: Aerie, Allergan, and Bausch + Lomb.

Gagan Sawhney, MD and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie, Allergan and New World Medical.

 

EDITORIAL SUPPORT DISCLOSURES

The Evolve staff and planners have no financial relationships with commercial interests. Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.

 

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve Medical Education LLC,  Aerie Pharmaceuticals, or Bausch + Lomb.

Pretest

  • 1 Not at all confident2 Not very confident3 Neutral4 Confident5 Extremely confident
  • 1 Never23 Neutral45 Always

Video Resources

Next

Test

Instructions

Step 1 of 2

50%
  • 1 Not at all confident2 Not very confident3 Neutral4 Confident5 Extremely confident
  • 1 Never23 Neutral45 Always
  • AgreeNeutralDisagree
    Identify the mechanisms of action as well as the efficacy and safety profiles of novel trabecular outflow medications
    Demonstrate proficiency in selecting appropriate therapies to achieve individualized patient-specific treatment goals
    Advocate for patients who would benefit from new drugs before they are incorporated into payors’ formularies
Back